Literature DB >> 12767410

Some methodologic issues in analyzing data from a randomized adolescent tobacco and alcohol use prevention trial.

Donald J Slymen1, John P Elder, Alan J Litrownik, Guadalupe X Ayala, Nadia R Campbell.   

Abstract

Three issues concerning the design and analysis of randomized behavioral intervention studies are illustrated and discussed within the framework of a tobacco and alcohol prevention trial among migrant Latino adolescents. The first issue arises when subjects are randomized in clusters rather than individually. Because subject observations cannot be assumed to be independent, information pertaining to the degree of clustering must be reported, and analyses must take the clustering into account. The second issue concerns the impact of compliance to the intervention and the importance of measuring compliance in the experimental and attention-control groups. A compliance analysis should control for participant contact with study personnel. Investigators must consider ways of constructing a compliance measure that is common to both conditions. Third, because outcomes are measured repeatedly over time, we illustrate the importance of assessing the impact of missing-data patterns on outcomes and the extent to which the patterns may modify the treatment effect.

Entities:  

Mesh:

Year:  2003        PMID: 12767410     DOI: 10.1016/s0895-4356(03)00012-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  The importance and role of intracluster correlations in planning cluster trials.

Authors:  John S Preisser; Beth A Reboussin; Eun-Young Song; Mark Wolfson
Journal:  Epidemiology       Date:  2007-09       Impact factor: 4.822

2.  A three-decade evolution to transdisciplinary research: community health research in California-Mexico border communities.

Authors:  John P Elder; Guadalupe X Ayala; Thomas L McKenzie; Alan J Litrownik; Linda C Gallo; Elva M Arredondo; Gregory A Talavera; Robert M Kaplan
Journal:  Prog Community Health Partnersh       Date:  2014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.